Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ex-situ oxygenated hypothermic machine perfusion in donation after circulatory death heart transplantation following either direct procurement or in-situ normothermic regional perfusion.
Moeslund N, Ertugrul IA, Hu MA, Dalsgaard FF, Ilkjaer LB, Ryhammer P, Pedersen M, Erasmus ME, Eiskjaer H. Moeslund N, et al. Among authors: hu ma. J Heart Lung Transplant. 2023 Jun;42(6):730-740. doi: 10.1016/j.healun.2023.01.014. Epub 2023 Feb 7. J Heart Lung Transplant. 2023. PMID: 36918339 Free article.
Establishing an economical and widely accessible donation after circulatory death animal abattoir model for lung research using ex vivo lung perfusion.
Zhang ZL, Moeslund N, Hu MA, Hoffmann R, Venema LH, Van De Wauwer C, Timens W, Okamoto T, Verschuuren EAM, Leuvenink HGD, Eiskjaer H, Erasmus ME. Zhang ZL, et al. Among authors: hu ma. Artif Organs. 2022 Nov;46(11):2179-2190. doi: 10.1111/aor.14345. Epub 2022 Jul 20. Artif Organs. 2022. PMID: 35730930 Free PMC article.
Effects of ketone body 3-hydroxybutyrate on cardiac and mitochondrial function during donation after circulatory death heart transplantation.
Seefeldt JM, Libai Y, Berg K, Jespersen NR, Lassen TR, Dalsgaard FF, Ryhammer P, Pedersen M, Ilkjaer LB, Hu MA, Erasmus ME, Nielsen RR, Bøtker HE, Caspi O, Eiskjær H, Moeslund N. Seefeldt JM, et al. Among authors: hu ma. Sci Rep. 2024 Jan 8;14(1):757. doi: 10.1038/s41598-024-51387-y. Sci Rep. 2024. PMID: 38191915 Free PMC article.
Ex Vivo Optimization of Donor Lungs with Inhaled Sevoflurane during Normothermic Ex Vivo Lung Perfusion (VITALISE): A Pilot and Feasibility Study in Sheep.
Steinkühler T, Yang S, Hu MA, Jainandunsing JS, Jager NM, Erasmus ME, Struys MMRF, Bosch DJ, van Meurs M, Jabaudon M, Richard D, Timens W, Leuvenink HGD, Nieuwenhuijs-Moeke GJ. Steinkühler T, et al. Among authors: hu ma. Int J Mol Sci. 2024 Feb 19;25(4):2413. doi: 10.3390/ijms25042413. Int J Mol Sci. 2024. PMID: 38397090 Free PMC article.
A Single-Arm Multi-Center Phase II Clinical Trial of Cadonilimab (anti-PD-1/CTLA-4) in Combination with or without Conventional Second-Line Treatment for Patients with Extensive Stage Small Cell Lung Cancer.
Chen C, Chen M, Bai Y, Li Y, Peng J, Yao B, Feng J, Zhou JG, Ma H. Chen C, et al. Among authors: ma h. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241249690. doi: 10.1177/15330338241249690. Technol Cancer Res Treat. 2024. PMID: 38706247 Free PMC article. Clinical Trial.
Exploring the optimal indicator of short-term peridiagnosis weight dynamics to predict cancer survival: A multicentre cohort study.
Yin L, Zhang L, Li L, Liu M, Zheng J, Xu A, Lyu Q, Feng Y, Guo Z, Ma H, Li J, Chen Z, Wang H, Li Z, Zhou C, Gao X, Weng M, Yao Q, Li W, Li T, Shi H, Xu H. Yin L, et al. Among authors: ma h. J Cachexia Sarcopenia Muscle. 2024 Apr 21. doi: 10.1002/jcsm.13467. Online ahead of print. J Cachexia Sarcopenia Muscle. 2024. PMID: 38644549 Free article.
TCCIA: a comprehensive resource for exploring CircRNA in cancer immunotherapy.
Wang S, Xiong Y, Zhang Y, Wang H, Chen M, Li J, Luo P, Luo YH, Hecht M, Frey B, Gaipl U, Li X, Zhao Q, Ma H, Zhou JG. Wang S, et al. Among authors: ma h. J Immunother Cancer. 2024 Jan 11;12(1):e008040. doi: 10.1136/jitc-2023-008040. J Immunother Cancer. 2024. PMID: 38212124 Free PMC article.
Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial.
Meng X, Zheng A, Wang J, Wu X, Li G, Zhu J, Ma H, Zhu X, Shi A, Dai C, Yan S, Wang B, Qu Z, Han C, Sun X, Ye M, Fan R, Huerxidan N, Wang X, Yu J. Meng X, et al. Among authors: ma h. Br J Cancer. 2023 Nov;129(11):1787-1792. doi: 10.1038/s41416-023-02388-7. Epub 2023 Oct 20. Br J Cancer. 2023. PMID: 37864049 Clinical Trial.
72 results